Biotech investment specialist Arch Venture Partners has hit a $1.85bn final close for its eleventh flagship fundraise, less than a year after hauling in almost $1.5bn for its predecessor vehicle.
Biotech investment specialist Arch Venture Partners has hit a $1.85bn final close for its eleventh flagship fundraise, less than a year after hauling in almost $1.5bn for its predecessor vehicle.